Ignite Creation Date:
2024-05-06 @ 7:16 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02508740
Status:
TERMINATED
Last Update Posted:
2015-07-27
First Post:
2015-07-22
Brief Title:
Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Renal Impairment |
Keywords: